report cover1

Crohn's Disease Treatment Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2023-2030

Crohn’s disease is a type of inflammatory bowel disease that may affect segments of the gastrointestinal tract. Symptoms often include abdominal pain, diarrhea, fever, abdominal distension, and weight loss. Complications outside of the gastrointestinal tract may include anemia, skin rashes, arthritis, inflammation of the eye, and fatigue. The skin rashes may be due to infections as well as pyoderma gangrenosum or erythema nodosum. Bowel obstruction may occur as a complication of chronic inflammation, and those with the disease are at greater risk of colon cancer and small bowel cancer. Although the precise cause of Crohn’s disease is unknown, it is believed to be caused by a combination of environmental, immune, and bacterial factors in genetically susceptible individuals. It results in a chronic inflammatory disorder, in which the body’s immune system defends the gastrointestinal tract, possibly targeting microbial antigens.  While Crohn’s is an immune-related disease.

There is no known cure for Crohn’s disease. Treatment options are intended to help with symptoms, maintain remission, and prevent relapse. In those newly diagnosed, a corticosteroid may be used for a brief period to rapidly improve symptoms, alongside another medication such as either methotrexate or thiopurine used to prevent recurrence. The diagnosis of Crohn’s disease can sometimes be challenging, and many tests are often required to assist the physician in making the diagnosis. However, Crohn’s disease is associated with a small increase in the risk of small bowel and colorectal carcinoma.

Global Crohn’s Disease Treatment Market – Competitive Landscape

On October 23, 2023, Roivant surged as Vivek Ramaswamy-found firm sold a bowel disease drug for USD 7.1 billion. On June 7, 2023, Mozart Therapeutics landed USD 25 million to develop therapies for autoimmune, and inflammatory diseases. On April 11, 2023, Oshi Health scored USD 30 million to scale a gastrointestinal care company. On May 25, 2021, Giiant raised USD 11 million for an advanced gut microbiota-activated IBD drug.

Some of the Key Players in the Global Crohn’s Disease Treatment Market Include –

  • AbbVie Inc
  • Takeda Pharmaceuticals
  • Eli Lilly
  • Pfizer Inc
  • AstraZeneca
  • Allergan
  • Amgen
  • Bayer
  • Celgene Corporation
  • Novartis AG
  • Sanofi
  • USB

Global Crohn’s Disease Treatment Market – Growth Drivers

The increasing prevalence of Crohn’s disease globally serves as a significant growth driver, propelling demand for effective treatments. According to Medline Plus the prevalence of Crohn’s disease is 100 to 300 per 100,000 people. Advances in medical research and a deeper understanding of the disease’s underlying mechanisms drive the development of innovative therapies, stimulating market growth. The rise in awareness about Crohn’s disease, coupled with improved diagnostic techniques, leads to early detection and intervention creating a larger patient pool in need of treatment. Growing healthcare infrastructure and the availability of advanced treatment options, particularly in developed regions, further contribute to market expansion. The adoption of biologics, such as monoclonal antibodies and other targeted therapies, represents a key growth driver. These advanced treatment modalities offer enhanced efficacy and improved outcomes, driving both patient and physician preference. Increasing investments in research and development, along with collaborations between pharmaceutical companies and research institutions, foster the development of novel drugs and treatment approaches. Moreover, the expansion of telemedicine and digital health solutions facilitates better disease management and patient care, contributing to the overall growth of the Crohn’s disease treatment market.

Global Crohn’s Disease Treatment Market – Restraints

the use of certain Crohn’s disease treatments, including biologics and immunosuppressants, may be associated with significant side effects, limiting patient adherence and posing safety concerns. The cost of advanced Crohn’s disease treatments, particularly biologics, can be substantial. Crohn’s disease costs about USD 30,000 for the first treatment alone. This financial burden may restrict access to these therapies for some patients and strain healthcare systems. There is a relative scarcity of approved treatments specifically designed for pediatric Crohn’s disease patients, presenting a challenge in adequately addressing the unique needs of this demographic. Treatment response can vary among individuals, making it challenging to predict the effectiveness of certain therapies for all patients. This variability complicates treatment decisions and necessitates a personalized approach. Some Crohn’s disease treatments may face challenges related to drug delivery, particularly in cases where oral administration is not feasible. This can impact patient compliance and treatment effectiveness. Over time, some patients may develop resistance to certain medications requiring a switch to alternative treatments. This poses a challenge in maintaining long-term efficacy and managing the disease effectively. Despite advancements, there are still gaps in the understanding of Crohn’s disease pathogenesis. This can hinder the development of targeted therapies and personalized medicine approaches. The chronic nature of Crohn’s disease, coupled with an unpredictable course of symptoms, can lead to a psychological course of symptoms, can lead to psychological and emotional challenges for patients, impacting their overall well-being and quality of life.

Global Crohn’s Disease Treatment Market – Opportunities

Advancements in biotechnology and the growing understanding of the disease’s underlying mechanisms offer potential for targeted therapies and personalized medicine. Expanding awareness and diagnosis rates in emerging markets create new avenues for market growth. Additionally, the rising adoption of biologics, such as anti-TNF agents, provides an opportunity for pharmaceutical companies to more effective and targeted biologic treatments. Advancements in telemedicine and digital health technologies open up opportunities for remote patient monitoring and improved disease management. The evolving landscape of Crohn’s disease treatment, coupled with increasing research and development activities, presents lucrative opportunities for stakeholders to address unmet medical needs and enhance patient outcomes.

Global Crohn’s Disease Treatment Market – Geographical Insight

The market for global Crohn’s disease treatment is segmented into regions such as North America, Latin America, Europe, Asia-Pacific, the Middle East & Africa. North America is the largest market for Crohn’s disease treatment due to the significant share due to the higher incidence of Crohn’s disease. In Europe, countries like the UK, Germany, and France also contribute substantially to the market, driven by improved healthcare infrastructure. Asia-Pacific is witnessing a rising prevalence of Crohn’s disease, and countries such as China and India are becoming important markets.

Global Crohn’s Disease Treatment Market – Key Development

  • On October 27, 2023, a Delayed FDA nod moved Lilly to the crowded uncreative colitis market.
  • On September 13, 2023, the FDA to start a review of subcutaneous Entyvio for Crohn’s disease.
  • On August 25, 2023, the FDA approved the first Tysabri biosimilar for MS and Crohn’s disease.
  • On February 2, 2023, MHRA approved the first oral advanced therapy for Crohn’s disease.
  • On June 17, 2022, the FDA approved Skyrizi for moderately to severely active Crohn’s disease.
Complete the form below and we'll get back to you shortly
Table of Content
Complete the form below and we'll get back to you shortly

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.



Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.


Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.
- Get Started -

Get insights that lead to new growth opportunities

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Buy Now
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert